Cabaletta Bio (CABA) Retained Earnings (2018 - 2025)
Cabaletta Bio's quarterly Retained Earnings came in at -$517.0 million in Q4 2025, down 48.08% year-on-year from -$995.7 million in Q4 2024, and down 2247739.13% quarter-over-quarter from $23000.0 in Q3 2025.
Cabaletta Bio has reported Retained Earnings for 8 years, with the latest figure at -$517.0 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 48.08% year-over-year to -$517.0 million; the trailing twelve-month figure through Dec 2025 stood at -$517.0 million (down 48.08% YoY), and the FY2025 full-year result was -$517.0 million, down 48.08% from the prior year.
- Retained Earnings for Q4 2025 stood at -$517.0 million, down from $23000.0 in the prior quarter.
- The five-year high for Retained Earnings was $39000.0 in Q4 2023, with the low at -$517.0 million in Q4 2025.
- Average Retained Earnings over 5 years is -$121.7 million, with a median of -$38.1 million recorded in 2021.
- Year-over-year, Retained Earnings tumbled 1876550.0% in 2021 and soared 2200.0% in 2025.
- Tracing CABA's Retained Earnings over 5 years: stood at -$112.6 million in 2021, then surged by 99.96% to -$47000.0 in 2022, then surged by 182.98% to $39000.0 in 2023, then tumbled by 895230.77% to -$349.1 million in 2024, then plunged by 48.08% to -$517.0 million in 2025.
- The last three Retained Earnings figures came in at -$517.0 million (Q4 2025), $23000.0 (Q3 2025), and -$430.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | -516.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -516.96 Mn |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | -430.17 Mn |
| Mar 31, 2025 | -385.04 Mn |
| Dec 31, 2024 | -349.10 Mn |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | -21,000.00 |
| Jun 30, 2023 | -195.90 Mn |
| Mar 31, 2023 | -181.42 Mn |
| Dec 31, 2022 | -47,000.00 |
| Sep 30, 2022 | -209,000.00 |
| Jun 30, 2022 | -249,000.00 |
| Mar 31, 2022 | -152,000.00 |
| Dec 31, 2021 | -112.59 Mn |
| Sep 30, 2021 | -98.70 Mn |
| Jun 30, 2021 | -87.14 Mn |
| Mar 31, 2021 | -76.00 Mn |
| Dec 31, 2020 | 6,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Jun 30, 2020 | -48.60 Mn |
| Mar 31, 2020 | -40.44 Mn |
| Dec 31, 2019 | -32.96 Mn |
| Sep 30, 2019 | -27.56 Mn |
| Dec 31, 2018 | -12.45 Mn |